Robuta

Background: Nasal high flow (NHF) has various effects on the respiratory system in acute and chronic conditions.

GGM, a dedicated high flow nasal cannula manufacturer established in 1997, is also one of the few respiratory care manufacturers in the market.

Individual/personal and contextual/environmental factors contribute to the use of HFNC therapy for infants with bronchiolitis. It is evident these influences...

Nov 25, 2025 - Revista Chilena de Anestesia Vol. 54 Num. 6 pp. 851-857 [...]

In these preterm infants with mild respiratory illness, HFNC provided support comparable to NCPAP.

HFNC is possible in the ED, and it alleviated dyspnea and improved respiratory parameters in subjects with acute hypoxemic respiratory failure.

HFNC therapy appears to be effective in patients with COVID-19 who develop respiratory failure requiring respiratory support. Non-critical COVID-19 and a...

clinicaltrials.gov Identifier: NCT01191489.